Histamine H3 receptor ligands with a 3-cyclobutoxy motif: a novel and versatile constraint of the classical 3-propoxy linker-Reference-Cited by-同舟云学术

Histamine H3 receptor ligands with a 3-cyclobutoxy motif: a novel and versatile constraint of the classical 3-propoxy linker

Published:2010 Issue:1 Volume:1 Page:39
ISSN:2040-2503
Container-title:MedChemComm
language:en
Short-container-title:Med. Chem. Commun.

Author:

Wijtmans Maikel,Denonne Frédéric,Célanire Sylvain,Gillard Michel,Hulscher Saskia,Delaunoy Christel,Van houtvin Nathalie,Bakker Remko A.,Defays Sabine,Gérard Julien,Grooters Luc,Hubert Delphine,Timmerman Henk,Leurs Rob,Talaga Patrice,de Esch Iwan J. P.,Provins Laurent

Publisher

Royal Society of Chemistry (RSC)

Subject

Pharmaceutical Science,Biochemistry,Drug Discovery,Molecular Medicine,Pharmacology,Organic Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2010/MD/C0MD00056F

Reference25 articles.

1. Genomics Meets Histamine Receptors: New Subtypes, New Receptors

2. Histamine H3receptor ligands break ground in a remarkable plethora of therapeutic areas

3. Histamine H3 Receptor Antagonists Go to Clinics

4. Keynote review: Histamine H3 receptor antagonists reach out for the clinic

5. Potential utility of histamine H3 receptor antagonist pharmacophore in antipsychotics

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selective P450_BM3 Hydroxylation of Cyclobutylamine and Bicyclo[1.1.1]pentylamine Derivatives: Underpinning Synthetic Chemistry for Drug Discovery;Journal of the American Chemical Society;2023-12-05

2. Puckering the Planar Landscape of Fragments: Design and Synthesis of a 3D Cyclobutane Fragment Library;ChemMedChem;2022-03-30

3. Bromo-Cyclobutenaminones as New Covalent UDP-N-Acetylglucosamine Enolpyruvyl Transferase (MurA) Inhibitors;Pharmaceuticals;2020-11-03

4. Synthesis and Characterization of a Bidirectional Photoswitchable Antagonist Toolbox for Real-Time GPCR Photopharmacology;Journal of the American Chemical Society;2018-02-22

5. Lead Generation Paved the Way for the Discovery of a Novel H 3 Inverse Agonist Clinical Candidate;Methods and Principles in Medicinal Chemistry;2016-03-04